V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009991 | 260006340 | 1.75 | 81 | Palliative (P) | 2013-05-09 | 2013-05-09 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260014560 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009992 | 260006340 | 0 | 64 | Curative (C) | 2018-11-05 | 2018-11-06 | Bleomycin + Cisplatin + Vinblastine | null | null | 260014560 | CISPLATIN + ETOPOSIDE |
| 260009993 | 260006341 | 1.55 | null | Curative (C) | 2018-01-16 | 2018-01-26 | Rituximab | 02 | N | 260014901 | CETUXIMAB |
| 260009994 | 260006342 | 1.66 | 53.8 | Disease modification (D) | 2017-03-05 | 2017-03-08 | Rituximab | 02 | N | 260014907 | CISPLATIN + ETOPOSIDE |
| 260009995 | 260006342 | 1.6 | null | Curative (C) | 2016-12-09 | 2016-12-13 | Cisplatin | N | N | 260014907 | RITUXIMAB |
| 260009996 | 260006343 | null | 90 | Palliative (P) | 2016-04-27 | 2016-05-05 | Rituximab | N | N | 260014992 | CISPLATIN + RT |
| 260009997 | 260006343 | 1.65 | 95.3 | Not known (9) | 2018-10-14 | 2018-10-15 | Rituximab | 02 | N | 260014992 | CHLORAMBUCIL + RITUXIMAB |
| 260009998 | 260006343 | 1.77 | 73 | null | 2018-03-02 | 2018-03-06 | EP | 02 | N | 260014992 | CISPLATIN + ETOPOSIDE |
| 260009999 | 260006344 | null | 76.1 | Curative (C) | 2017-11-22 | 2017-11-28 | 111 Trial (formerly BEP 111) | N | N | 260015253 | TRASTUZUMAB |
| 260010000 | 260006344 | null | 68 | Curative (C) | 2016-06-14 | 2016-06-14 | Rituximab (Maintenance) | N | N | 260015253 | CARBOPLATIN + PACLITAXEL |
| 260010001 | 260006344 | 1.77 | 125.5 | Palliative (P) | 2016-04-23 | 2016-05-19 | Rituximab (Maintenance) | N | N | 260015253 | ETOPOSIDE |
| 260010002 | 260006344 | 1.67 | 76 | Disease modification (D) | 2018-06-14 | 2018-06-14 | TIP | 02 | N | 260015253 | EP |
| 260010003 | 260018403 | 1.82 | 76 | Curative (C) | 2017-05-23 | 2017-06-22 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 01 | null | 260015423 | CARBOPLATIN + PEMETREXED |
| 260010004 | 260006345 | 1.7 | 90.96 | Disease modification (D) | 2014-01-21 | 2014-02-01 | Rituximab | N | N | 260015462 | NOT MATCHED |
| 260010005 | 260006345 | 1.69 | 67.7 | Curative (C) | 2013-08-29 | 2013-10-02 | TIP | N | Y | 260015462 | CARBOPLATIN + ETOPOSIDE |
| 260010006 | 260006346 | null | 98.7 | Palliative (P) | null | 2018-04-28 | Cisplatin + Etoposide (5 day) | null | null | 260015476 | CARBOPLATIN + ETOPOSIDE |
| 260010007 | 260006346 | null | 105.4 | Disease modification (D) | 2019-05-08 | 2019-05-11 | CISPLATIN + ETOPOSIDE | N | N | 260015476 | CARBOPLATIN + ETOPOSIDE |
| 260010008 | 260006347 | 1.78 | 72.4 | Not known (9) | 2018-02-04 | 2018-02-04 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260015668 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010009 | 260006347 | 1.74 | 83.5 | Neo-adjuvant (N) | 2014-06-25 | 2014-06-26 | ETOPOSIDE | 02 | Y | 260015668 | CVP |
| 260010010 | 260006347 | 1.77 | null | Palliative (P) | 2018-10-27 | 2018-10-27 | CISPLATIN + ETOPOSIDE | N | N | 260015668 | METHOTREXATE INTRATHECAL |
| 260010011 | 260006348 | 1.73 | 85.8 | Disease modification (D) | 2015-04-28 | 2015-04-28 | Cisplatin + Etoposide (5 day) | N | N | 260015834 | CISPLATIN + ETOPOSIDE |
| 260010012 | 260006349 | 1.77 | 70.6 | Palliative (P) | 2018-08-28 | 2018-09-20 | Cisplatin | N | N | 260015843 | CARBOPLATIN + PACLITAXEL |
| 260010013 | 260012449 | 1.73 | 84 | Palliative (P) | null | 2015-08-27 | Rituximab | N | N | 260015858 | FCR |
| 260010014 | 260006350 | 1.9 | null | Disease modification (D) | 2016-02-02 | 2016-02-08 | POMB | N | N | 260015955 | CISPLATIN + ETOPOSIDE |
| 260010015 | 260006351 | null | null | Palliative (P) | 2016-09-06 | 2016-09-13 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260015974 | CISPLATIN + ETOPOSIDE |
| 260010016 | 260006351 | null | 112.1 | Palliative (P) | 2016-03-31 | 2016-04-18 | Trial Unspecified | N | N | 260015974 | CARBOPLATIN + ETOPOSIDE |
| 260010017 | 260006352 | 1.79 | null | Palliative (P) | 2015-11-07 | 2015-11-20 | EP | N | N | 260016014 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260010018 | 260006353 | 1.83 | 107.4 | Palliative (P) | 2018-05-30 | 2018-08-01 | ABVD | 02 | N | 260016020 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260010019 | 260006353 | 1.71 | 50.5 | Curative (C) | 2018-02-24 | 2018-02-25 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 260016020 | CHOP |
| 260010020 | 260006354 | 1.76 | 57 | Curative (C) | 2014-03-23 | 2014-04-28 | Bendamustine + prednisolone | N | N | 260016062 | FEC |
| 260010021 | 260012452 | null | 108.2 | null | null | 2018-06-12 | Trial Unspecified | null | null | 260016128 | CISPLATIN + ETOPOSIDE |
| 260010022 | 260012452 | 1.68 | 60 | Curative (C) | 2016-05-26 | 2016-06-03 | EP 1 2 or 3 day | 2 | N | 260016128 | CISPLATIN + ETOPOSIDE |
| 260010023 | 260006355 | 1.72 | 84.2 | Curative (C) | 2014-04-04 | 2014-04-16 | Cisplatin | N | N | 260016186 | RITUXIMAB |
| 260010024 | 260012453 | 1.75 | 74 | Curative (C) | null | 2016-03-11 | Carboplatin + Etoposide IV 3 day | N | N | 260016204 | GEMCARBO |
| 260010025 | 260012453 | 1.67 | 63.2 | Palliative (P) | null | 2017-07-26 | EVEROLIMUS | N | null | 260016204 | RITUXIMAB |
| 260010026 | 260006356 | 1.83 | null | Not known (9) | 2016-07-01 | 2016-07-22 | Cisplatin + Etoposide (5 day) | 1 | null | 260016240 | RITUXIMAB |
| 260010027 | 260012454 | 1.65 | 73.6 | null | null | 2014-12-03 | CHOP - 21 days | N | null | 260016339 | FCR |
| 260010028 | 260006357 | 1.85 | 85.5 | Palliative (P) | null | 2018-07-24 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260016346 | CARBOPLATIN + ETOPOSIDE |
| 260010029 | 260006357 | null | null | Adjuvant (A) | 2016-09-13 | 2016-09-15 | ETOPOSIDE | N | N | 260016346 | CISPLATIN + ETOPOSIDE |
| 260010030 | 260006357 | 1.82 | null | Curative (C) | 2015-03-17 | 2015-03-24 | Rituximab | null | N | 260016346 | RITUXIMAB |
| 260010031 | 260006357 | 1.76 | 110 | Curative (C) | 2018-02-15 | 2018-03-06 | Trial Unspecified | N | N | 260016346 | IVA |
| 260010032 | 260006357 | 1.75 | 85 | Adjuvant (A) | 2019-03-06 | 2019-03-06 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 260016346 | CISPLATIN + ETOPOSIDE |
| 260010033 | 260006357 | null | null | Disease modification (D) | 2014-04-28 | 2014-04-30 | BENDAMUSTINE | N | N | 260016346 | BENDAMUSTINE |
| 260010034 | 260006358 | 1.58 | null | Neo-adjuvant (N) | 2014-10-26 | 2014-10-26 | Rituximab | 02 | N | 260016494 | FCR |
| 260010035 | 260006358 | 1.64 | 47.5 | Palliative (P) | 2017-06-12 | 2017-06-22 | FEC 60 or 75 | N | N | 260016494 | RITUXIMAB |
| 260010036 | 260006358 | 1.88 | 58 | Palliative (P) | 2014-12-26 | 2014-12-26 | CISPLATIN + ETOPOSIDE | 02 | N | 260016494 | CISPLATIN + ETOPOSIDE |
| 260010037 | 260006359 | 0 | 60 | Curative (C) | 2014-07-17 | 2014-07-19 | POMB/ACE | N | N | 260016640 | CISPLATIN + ETOPOSIDE |
| 260010038 | 260006359 | null | 75.3 | Curative (C) | 2014-05-17 | 2014-06-05 | Bleomycin + Cisplatin + Vinblastine | N | N | 260016640 | POMB |
| 260010039 | 260006359 | 1.7 | 99.6 | null | null | 2018-01-05 | Doxorubicin + Olaratumab | N | N | 260016640 | TRIAL |
| 260010040 | 260006359 | null | null | null | 2017-07-08 | 2017-07-21 | CARBOPLATIN + ETOPOSIDE | N | N | 260016640 | ETOPOSIDE |